Recent research showed that GLP-1R has the promising ability to generate neuroprotection against neurological disorders, including Alzheimer’s disease (AD), Parkinson’s disease (PD), amyotrophic lateral sclerosis (ALS) and ischaemic stroke18, 19. This evidence concerns the gene GLP1R and early-onset autosomal dominant Alzheimer disease.